Clinical Trial Update: Actos Now for Prevention of Diabetes (ACT NOW) [Phase 3]

View source ↗

Summary

Phase 3 trial of Actos (pioglitazone) for prevention of diabetes in people with impaired glucose tolerance; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Impaired Glucose Tolerance, Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2016-08-11